Published in
Elsevier, Lancet Haematology, 9(7), p. e649-e659, 2020
DOI: 10.1016/s2352-3026(20)30208-8
Links
Tools
Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study
Journal article published in 2020 by
Jean-Marie Michot,
Reda Bouabdallah,
Umberto Vitolo,
Jeanette K. Doorduijn,
Gilles Salles,
Annalisa Chiappella,
Pier Luigi Zinzani,
Fontanet Bijou,
Marie José Kersten,
Rafael Sarmiento,
Silvia Mosulen,
Cristina Mendez,
Shailaja Uttamsingh,
Michael Pourdehnad 
,
Kristen Hege
and other authors.
,
Kristen Hege
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 